Acomprehensive assessment, including clinical parameters and laboratorial (white blood count and C-reactive protein) and radiological data, should be made to evaluate the possible presence of a SARS-CoV-2 gastrointestinal infection and to monitor and evaluate the severity and prognosis of the disease [21,22]. The gene discussed is CRP; the disease is digestive system infectious disorder.